The first patient of human-derived mesenchymal stem cell culture supernatant (exosome) therapy
Aging treatment has been working in our clinic since last year.
Thanks to all of you because it became popular today.
NMN (nicotinamide mononucleotide) drip therapy started in April last year.
And in June, I started hydrogen gas inhalation therapy.
The number of users of each therapy is increasing.
Moreover
as the third arrow of aging treatment,
we started human-derived mesenchymal stem cell culture supernatant (exosomes) therapy at our clinic from this week.
This therapy is aimed at customer’s own
anti-aging
as well as
improvement of decline due to aging, etc.
One way to achieve these goals is
the culture supernatant (excluding cells), obtained by culturing human-derived mesenchymal stem cells, is administered.
The stem cell culture supernatant used in our clinic obtained by culturing human-derived mesenchymal stem cells (those whose safety has been confirmed by testing for infectious diseases).
It contains cytokines (growth factors) and abundant exosomes (a type of extracellular endoplasmic reticulum), which have been attracting attention recently.
The expected effect is appeared by the work of cytokines and exosomes contained in stem cell culture supernatant as below:
By subcutaneous injection
Improvement of skin firmness and wrinkles
Whitening effect
Hair growth effect
Decrease in gray hair, etc.
On the other hand,
By intravenous drip
Targets of this treatment like according to stem cell therapy as follow:
Cranial nerve
Neurodegeneration
Cardiology
Respiratory
Digestive organ
Metabolism
Immunity
and
Malignant tumor.
There are a wide range of reports, including the effects of this aging treatment.